Security key
00847X104
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)
CUSIP: 00847X104
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock, Par Value $0.001 per share
- Shares outstanding
- 59,431,072
- Total 13F shares
- 46,986,627
- Share change
- +928,375
- Total reported value
- $2,686,172,197
- Put/Call ratio
- 121%
- Price per share
- $57.17
- Number of holders
- 173
- Value change
- +$50,530,934
- Number of buys
- 88
- Number of sells
- 78
Report period
Q4 2017
Institutions
173
Top holders
10
AGIO full security history
Newer quarter: Q1 2018
Previous quarter: Q3 2017
AGIOS PHARMACEUTICALS, INC. SEC filings
AGIOS PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00847X104
Recent filing periods:
Top shareholders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
12%
|
7,258,679
|
$484,517,000 | — | 30 Sep 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
11%
|
6,769,790
|
$451,883,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.5%
|
3,290,167
|
$219,619,000 | — | 30 Sep 2017 | |
| Capital International Investors |
13F
|
Company |
5.3%
|
3,138,131
|
$209,470,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.8%
|
2,871,626
|
$191,682,000 | — | 30 Sep 2017 | |
| BB BIOTECH AG |
13F
|
Company |
4.6%
|
2,749,998
|
$183,562,000 | — | 30 Sep 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.9%
|
1,747,136
|
$116,621,000 | — | 30 Sep 2017 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.6%
|
1,528,895
|
$102,054,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,255,721
|
$83,816,000 | — | 30 Sep 2017 | |
| Invesco Ltd. |
13F
|
Company |
1.7%
|
985,932
|
$65,810,000 | — | 30 Sep 2017 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.6%
|
966,152
|
$64,491,000 | — | 30 Sep 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.6%
|
932,156
|
$62,221,000 | — | 30 Sep 2017 | |
| COLUMBIA WANGER ASSET MANAGEMENT LLC |
13F
|
Company |
1.5%
|
889,142
|
$59,350,000 | — | 30 Sep 2017 | |
| CAPITAL GUARDIAN TRUST CO |
13F
|
Company |
1.2%
|
729,714
|
$48,708,000 | — | 30 Sep 2017 | |
| Capital World Investors |
13F
|
Company |
1.1%
|
663,000
|
$44,255,000 | — | 30 Sep 2017 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
1.1%
|
644,316
|
$43,008,000 | — | 30 Sep 2017 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.83%
|
491,203
|
$32,788,000 | — | 30 Sep 2017 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.77%
|
456,761
|
$30,489,000 | — | 30 Sep 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.76%
|
450,000
|
$30,038,000 | — | 30 Sep 2017 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.65%
|
388,536
|
$25,935,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.61%
|
365,439
|
$24,393,000 | — | 30 Sep 2017 | |
| NORGES BANK |
13F
|
Company |
0.53%
|
316,476
|
$21,125,000 | — | 30 Sep 2017 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.49%
|
291,139
|
$19,433,000 | — | 30 Sep 2017 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.43%
|
256,086
|
$17,094,000 | — | 30 Sep 2017 | |
| Casdin Capital, LLC |
13F
|
Company |
0.43%
|
255,000
|
$17,021,000 | — | 30 Sep 2017 | |
| CAPITAL INTERNATIONAL LTD /CA/ |
13F
|
Company |
0.41%
|
241,337
|
$16,109,000 | — | 30 Sep 2017 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.4%
|
238,381
|
$15,972,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.38%
|
228,626
|
$15,261,000 | — | 30 Sep 2017 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.36%
|
214,000
|
$14,285,000 | — | 30 Sep 2017 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.36%
|
211,598
|
$14,124,000 | — | 30 Sep 2017 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.35%
|
208,000
|
$13,884,000 | — | 30 Sep 2017 | |
| PDT Partners, LLC |
13F
|
Company |
0.31%
|
186,101
|
$12,422,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.3%
|
176,404
|
$11,775,000 | — | 30 Sep 2017 | |
| Quantitative Investment Management, LLC |
13F
|
Company |
0.28%
|
166,600
|
$11,120,000 | — | 30 Sep 2017 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.28%
|
166,065
|
$11,085,000 | — | 30 Sep 2017 | |
| AXA S.A. |
13F
|
Company |
0.27%
|
161,743
|
$10,796,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.25%
|
147,741
|
$9,859,000 | — | 30 Sep 2017 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.23%
|
138,368
|
$9,236,000 | — | 30 Sep 2017 | |
| Capital International Sarl |
13F
|
Company |
0.22%
|
130,800
|
$8,731,000 | — | 30 Sep 2017 | |
| Opaleye Management Inc. |
13F
|
Company |
0.22%
|
130,000
|
$8,677,000 | — | 30 Sep 2017 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.22%
|
129,640
|
$8,653,000 | — | 30 Sep 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.22%
|
128,666
|
$8,588,000 | — | 30 Sep 2017 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.2%
|
121,390
|
$8,103,000 | — | 30 Sep 2017 | |
| Capital Bank & Trust Co |
13F
|
Company |
0.2%
|
121,195
|
$8,090,000 | — | 30 Sep 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
115,995
|
$7,743,000 | — | 30 Sep 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.19%
|
112,813
|
$7,530,000 | — | 30 Sep 2017 | |
| Clarius Group, LLC |
13F
|
Company |
0.18%
|
109,230
|
$7,291,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.17%
|
102,912
|
$6,869,000 | — | 30 Sep 2017 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.16%
|
97,500
|
$6,508,000 | — | 30 Sep 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.16%
|
94,000
|
$6,275,000 | — | 30 Sep 2017 |
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) as of Q4 2017
As of 31 Dec 2017,
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) was held by
173 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,986,627 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, Capital International Investors, BlackRock Inc., BB BIOTECH AG, PRICE T ROWE ASSOCIATES INC /MD/, Clearbridge Investments, LLC, STATE STREET CORP, and Balyasny Asset Management LLC.
This page lists
173
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
168
Q4 2017 holders
173
Holder diff
5
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.